|
产品编号 |
中文名称 |
英文名称 |
Cas号 |
|
Reactive Rhodamine |
|
|
|
|
SCPP-203145 |
5-四甲基罗丹明-二苯并环辛炔 |
5-TAMRA-DBCO |
2071694-39-6 |
|
SCPP-203144 |
5-四甲基罗丹明-5-四嗪 |
5-TAMRA-Tetrazine |
1393381-53-7 |
|
SCPP-203143 |
5-羧基四甲基罗丹明-炔烃 |
5-TAMRA-Alkyne |
945928-17-6 |
|
SCPP-203142 |
5-四甲基罗单明叠氮化物 |
5-TAMRA-N3 |
825651-66-9 |
|
SCPP-203141 |
5-四甲基罗单明氨基化物 |
5-TAMRA-NH2 |
2158336-48-0 |
|
SCPP-203140 |
四甲基罗丹明-活性酯 |
5-TAMRA-NHS |
321862-17-3 |
|
SCPP-203139 |
6-羧基四甲基罗丹明 |
6-TAMRA-COOH |
91809-67-5 |
|
SCPP-203138 |
5-羧基四甲基罗丹明 |
5-TAMRA-COOH |
91809-66-4 |
|
RGD PEG |
|
|
|
|
SCPP-202875 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基，分子量5k |
cRGD-PEG-COOH,Mw 5k |
N/A |
|
SCPP-202874 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基，分子量3.4k |
cRGD-PEG-COOH,Mw 3.4k |
N/A |
|
SCPP-202873 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基，分子量2k |
cRGD-PEG-COOH,Mw 2k |
N/A |
|
SCPP-202872 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基，分子量5k |
RGD-PEG-COOH,Mw 5k |
N/A |
|
SCPP-202871 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基，分子量3.4k |
RGD-PEG-COOH,Mw 3.4k |
N/A |
|
SCPP-202870 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-羧基，分子量2k |
RGD-PEG-COOH,Mw 2k |
N/A |
|
SCPP-202400 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量600 |
iRGD-PEG-SH,Mw 600 |
N/A |
|
SCPP-202399 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量5k |
iRGD-PEG-SH,Mw 5k |
N/A |
|
SCPP-202398 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量400 |
iRGD-PEG-SH,Mw 400 |
N/A |
|
SCPP-202397 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量3.4k |
iRGD-PEG-SH,Mw 3.4k |
N/A |
|
SCPP-202396 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量2k |
iRGD-PEG-SH,Mw 2k |
N/A |
|
SCPP-202395 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量10k |
iRGD-PEG-SH,Mw 10k |
N/A |
|
SCPP-202394 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量1k |
iRGD-PEG-SH,Mw 1k |
N/A |
|
SCPP-202393 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮，分子量5k |
iRGD-PEG-N3,Mw 5k |
N/A |
|
SCPP-202392 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮，分子量3.4k |
iRGD-PEG-N3,Mw 3.4k |
N/A |
|
SCPP-202391 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮，分子量2k |
iRGD-PEG-N3,Mw 2k |
N/A |
|
SCPP-202390 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮，分子量10k |
iRGD-PEG-N3,Mw 10k |
N/A |
|
SCPP-202389 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮，分子量1k |
iRGD-PEG-N3,Mw 1k |
N/A |
|
SCPP-202388 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺，分子量5k |
iRGD-PEG-MAL,Mw 5k |
N/A |
|
SCPP-202387 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺，分子量3.4k |
iRGD-PEG-MAL,Mw 3.4k |
N/A |
|
SCPP-202386 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺，分子量2k |
iRGD-PEG-MAL,Mw 2k |
N/A |
|
SCPP-202382 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量600 |
cRGD-PEG-SH,Mw 600 |
N/A |
|
SCPP-202381 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量5k |
cRGD-PEG-SH,Mw 5k |
N/A |
|
SCPP-202380 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量400 |
cRGD-PEG-SH,Mw 400 |
N/A |
|
SCPP-202379 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量3.4k |
cRGD-PEG-SH,Mw 3.4k |
N/A |
|
SCPP-202378 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量2k |
cRGD-PEG-SH,Mw 2k |
N/A |
|
SCPP-202377 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量10k |
cRGD-PEG-SH,Mw 10k |
N/A |
|
SCPP-202376 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量1k |
cRGD-PEG-SH,Mw 1k |
N/A |
|
SCPP-202375 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮，分子量5k |
cRGD-PEG-N3,Mw 5k |
N/A |
|
SCPP-202374 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮，分子量3.4k |
cRGD-PEG-N3,Mw 3.4k |
N/A |
|
SCPP-202373 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮，分子量2k |
cRGD-PEG-N3,Mw 2k |
N/A |
|
SCPP-202372 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮，分子量10k |
cRGD-PEG-N3,Mw 10k |
N/A |
|
SCPP-202371 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-叠氮，分子量1k |
cRGD-PEG-N3,Mw 1k |
N/A |
|
SCPP-202367 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基，分子量5k |
cRGD-PEG-NH2,Mw 5k |
N/A |
|
SCPP-202366 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基，分子量3.4k |
cRGD-PEG-NH2,Mw 3.4k |
N/A |
|
SCPP-202365 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基，分子量2k |
cRGD-PEG-NH2,Mw 2k |
N/A |
|
SCPP-202359 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量600 |
RGD-PEG-SH,Mw 600 |
N/A |
|
SCPP-202358 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量5k |
RGD-PEG-SH,Mw 5k |
N/A |
|
SCPP-202357 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量400 |
RGD-PEG-SH,Mw 400 |
N/A |
|
SCPP-202356 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量3.4k |
RGD-PEG-SH,Mw 3.4k |
N/A |
|
SCPP-202355 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量2k |
RGD-PEG-SH,Mw 2k |
N/A |
|
SCPP-202354 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量10k |
RGD-PEG-SH,Mw 10k |
N/A |
|
SCPP-202353 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-巯基，分子量1k |
RGD-PEG-SH,Mw 1k |
N/A |
|
SCPP-202347 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺，分子量5k |
RGD-PEG-MAL,Mw 5k |
N/A |
|
SCPP-202346 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺，分子量3.4k |
RGD-PEG-MAL,Mw 3.4k |
N/A |
|
SCPP-202345 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-马来酰亚胺，分子量2k |
RGD-PEG-MAL,Mw 2k |
N/A |
|
SCPP-202344 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基，分子量5k |
RGD-PEG-NH2,Mw 5k |
N/A |
|
SCPP-202343 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基，分子量3.4k |
RGD-PEG-NH2,Mw 3.4k |
N/A |
|
SCPP-202342 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-氨基，分子量2k |
RGD-PEG-NH2,Mw 2k |
N/A |
|
SCPP-201339 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-活性酯，分子量5k |
RGD-PEG-NHS,Mw 5k |
N/A |
|
SCPP-201338 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-活性酯，分子量3.4k |
RGD-PEG-NHS,Mw 3.4k |
N/A |
|
SCPP-201337 |
整合素靶向肽 (肿瘤新生血管靶向肽)-聚乙二醇-活性酯，分子量2k |
RGD-PEG-NHS,Mw 2k |
N/A |
